Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04787848
NA
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
Sponsor: Florida International University
View on ClinicalTrials.gov
Summary
To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
Official title: Role of Endogenous Opioid Peptides in HIV-associated Chronic Widespread Pain
Key Details
Gender
All
Age Range
19 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2021-11-15
Completion Date
2026-07-30
Last Updated
2026-01-14
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Relistor Injectable Product
Relistor is a peripherally acting opioid receptor antagonist approved by the FDA for relief of opioid-induced constipation
Locations (1)
Ambulatory Care Center, Florida International University
Miami, Florida, United States